Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | QGEN Qiagen N.V. Common | ABBV AbbVie |
|---|---|---|
| Price | $44.20 -1.3% | $264.48 +0.2% |
| StockIQ Score | 76B+ Strong Risk: High | 54C- Moderate Risk: High |
| Technical | 77B+ | 82A- |
| Fundamental | — | 57C |
| Growth | — | 34F |
| Fair Value | — | 33F |
| News | 92A+ | 62C+ |
| Quality | — | 42D |
| Risk | 42D | 36F |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Qiagen (QGEN) outperforms AbbVie (ABBV) in investor confidence and technical strength, scoring 52 and 36 respectively, compared to AbbVie’s 42 and 29. AbbVie leads in fundamentals, growth, and valuation, with scores of 56, 34, and 33, while Qiagen lacks those details. Qiagen’s moderate rating also suggests steadier investor sentiment than AbbVie’s weaker classification.